Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD
0.0970
0.00 (0.00%)
Apr 21, 2026, 2:54 PM HKT
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 |
|---|
Medical and Healthcare Services | 21.31M | 19.05M | 13.04M | 14.97M | 7.35M | | | | | |
Medical and Healthcare Services Growth | 11.86% | 46.12% | -12.90% | 103.62% | 57.02% | | | | | |
Chinese Medicine Business (Excluding Medical and Healthcare Services) | 56.21M | 29.49M | 51.80M | - | 107.55M | | | | | |
Chinese Medicine Business (Excluding Medical and Healthcare Services) Growth | 90.56% | -43.06% | - | - | -4.50% | | | | | |
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) | 245.43M | 285.71M | 471.20M | 462.64M | 396.50M | | | | | |
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) Growth | -14.10% | -39.36% | 1.85% | 16.68% | 10.74% | | | | | |
Elimination of Intersegment Sales | - | -4.32M | -3.94M | -5.14M | -1.45M | | | | | |
| - | - | - | 74.23M | - | | | | | |
| 322.95M | 329.94M | 532.09M | 546.69M | 509.96M | | | | | |
| -2.12% | -37.99% | -2.67% | 7.20% | 7.51% | | | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 |
|---|
| 315.14M | 320.99M | 524.13M | 538.11M | 505.95M | | | | | |
| -1.82% | -38.76% | -2.60% | 6.36% | 7.11% | | | | | |
| 6.39M | 7.74M | 6.47M | 7.71M | 3.64M | | | | | |
| -17.54% | 19.62% | -16.02% | 111.99% | 131.65% | | | | | |
| 1.42M | 1.20M | 1.49M | 880.00K | 366.00K | | | | | |
| 18.05% | -19.33% | 69.32% | 140.44% | -2.22% | | | | | |
| 322.95M | 329.94M | 532.09M | 546.69M | 509.96M | | | | | |
| -2.12% | -37.99% | -2.67% | 7.20% | 7.51% | | | | | |
Source: S&P Global Market Intelligence.
